Biotech Stocks Facing FDA Decision In November 2020

On October 22, the FDA approved Gilead's (GILD) Veklury (remdesivir), the first drug for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Let's take a look at the companies that await a ruling from the FDA in November.